Clinicopathological Significance of Taz and VGLL1 Expression in Early Stage Ovarian Cancer. A study by Spanish Group for Ovarian Cancer Research (GEICO).

被引：0
|
作者：
Antonio Lopez-Guerrero, Jose
Gutierrez Pecharroman, Ana
Palacios, Jose
Cristobal Lana, Eva Maria
Romero, Ignacio
Hardisson, David
Vera-Sempere, Francisco
Illueca, Carmen
Vieites, Begoaa
Garcia, Angel
Ibarra de la Rosa, Javier
Alonso, Sofia Hakin
Guarch Troyas, Rosa
Andrada, Encarna
Montes, Santiago
Pastor, Francisco
Carmen Gomez, Maria
Amparo Torroba, Maria
D'Angelo, Emanuela
Poveda, Andres
机构：
[1] Inst Valenciano Oncol, Mol Biol Lab, Valencia, Spain
[2] Hosp Ramon & Cajal, E-28034 Madrid, Spain
[3] Hosp Univ Ramon y Cajal, Dept Pathol, Madrid, Spain
[4] Inst Valenciano Oncol, Valencia, Spain
[5] IdiPAZ, Hosp Univ La Paz, Dept Pathol, Madrid, Spain
[6] Hosp Univ La Fe, Valencia, Spain
[7] Inst Valenciano Oncol, Area Clin Oncol Ginecol, Valencia, Spain
[8] Hosp Virgen del Rocio, Seville, Spain
[9] Vall dHebron Univ Hosp, Dept Pathol, Barcelona, Spain
[10] Hosp Son Llatzer, Palma De Mallorca, Spain
[11] Hosp Miguel Servet, Zaragoza, Spain
[12] Hosp Navarra, Pamplona, Spain
[13] Hosp Gen Elche, Elche, Spain
[14] Hosp Marques de Valdecillas, Santander, Spain
[15] Univ Hosp Reina Sofia, Murcia, Spain
[16] Hosp Badalona Germans Trias & Pujol, Dept Pathol, Barcelona, Spain
[17] Hosp Virgen Arrixaca, Murcia, Spain
[18] Hosp Santa Creu & Sant Pau, Barcelona, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
10.1200/jco.2015.33.15_suppl.e16583
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16583
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Analysis of Gene Expression in Early-Stage Ovarian Cancer
    Marchini, Sergio
    Mariani, Pietro
    Chiorino, Giovanna
    Marrazzo, Eleonora
    Bonomi, Riccardo
    Fruscio, Robert
    Clivio, Luca
    Garbi, Annalisa
    Torri, Valter
    Cinquini, Michela
    Dell'Anna, Tiziana
    Apolone, Giovanni
    Broggini, Massimo
    D'Incalci, Maurizio
    CLINICAL CANCER RESEARCH, 2008, 14 (23) : 7850 - 7860
  • [32] N6-methyladenosine-modified VGLL1 promotes ovarian cancer metastasis through high-mobility group AT-hook 1/Wnt/β-catenin signaling
    Li, Han
    Cai, Liming
    Pan, Qiuzhong
    Jiang, Xingyu
    Zhao, Jingjing
    Xiang, Tong
    Tang, Yan
    Wang, Qijing
    He, Jia
    Weng, Desheng
    Zhang, Yanna
    Liu, Zhongqiu
    Xia, Jianchuan
    ISCIENCE, 2024, 27 (05)
  • [33] Clinicopathological, predictive and prognostic significance of XRCC1-Ligase III heterodimer expression in ovarian cancer
    Alabdullah, M. L.
    Moseley, P.
    Chan, S.
    Rakha, E.
    Madhusudan, S.
    ANNALS OF ONCOLOGY, 2018, 29
  • [34] Optimizing DNA processing and ovarian cancer methylation-specific PCR assays for the detection of early-stage ovarian cancer.
    Warton, Kristina
    Yuwono, Nicole
    Henry, Claire
    Hacker, Neville
    Ford, Caroline
    CLINICAL CANCER RESEARCH, 2020, 26 (13) : 93 - 93
  • [35] High throughput multidimensional mass spectrometry analysis for the detection of early stage epithelial ovarian cancer: A serum test for ovarian cancer.
    Fishman, DA
    Hao, ZQ
    Pelt, V
    Petricoin, EF
    Liotta, LA
    Wiggins, WS
    Seshaiah, P
    Coleman, TA
    Hitt, BA
    JOURNAL OF THE SOCIETY FOR GYNECOLOGIC INVESTIGATION, 2004, 11 (02) : 154A - 154A
  • [36] BRCA1 AND PARP 1 IMMUNOHISTOCHEMICAL EXPRESSION IN OVARIAN CANCER.
    Resta, L.
    Cascarano, M. A.
    Serio, G.
    Cormio, G.
    Zannoni, G.
    Arciulo, D.
    Cicinelli, E.
    Loizzi, V.
    Marzullo, A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 : 513 - 513
  • [37] Clinical significance of HUWE1 expression in ovarian cancer
    Podgorska, A.
    Rembiszewska, A.
    Szafron, L.
    Konopka, B.
    Lukasik, M.
    Budzilowska, A.
    Kupryjanczyk, J.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S94 - S94
  • [38] Ovarian preservation among women with early stage cervical cancer. A retrospective evaluation of the incidence of ovarian metastasis.
    Billod, Jimmy A.
    Domingo, Efren Javier
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [39] Tampa Bay ovarian cancer study: A population-based study of BRCA1/2 in ovarian cancer.
    Pal, T
    Krischer, JF
    Betts, JA
    Wey, JP
    Fiorica, J
    Grendys, E
    Martino, M
    LaPolla, J
    Arango, H
    Wakely, K
    Hoffman, M
    Wilbanks, G
    Nicosia, S
    Sutphen, R
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2003, 12 (11) : 1341S - 1341S
  • [40] Tampa Bay Ovarian Cancer Study - A population-based study of BRCA1/2 in ovarian cancer.
    Pal, T
    Krischer, JP
    Holtje, T
    Betts, JA
    Permuth-Wey, J
    Fiorica, J
    Grendys, E
    LaPolla, J
    Arango, H
    Wakeley, K
    Hoffman, M
    Wilbanks, G
    Nicosia, S
    Sutphen, R
    AMERICAN JOURNAL OF HUMAN GENETICS, 2002, 71 (04) : 250 - 250
12345